Françoise Stanke-Labesque

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 5

Top Topics

Molecularly Imprinted

End Stage Renal Disease

Ulcerative Colitis

Liquid Chromatography Tandem Mass Spectrometry

Top Venues

British journal of clinical pharmacology

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Léa Bolcato, Charles Khouri, Anette Veringa, Jan Willem C Alffenaar, Takahiro Yamada, Takafumi Naito, Fabien Lamoureux, Xavier Fonrose, Françoise Stanke-Labesque, Elodie Gautier-Veyret
Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual Data. Journal of clinical medicine 10 (10) (2021)
Edouard Bonneville, Elodie Gautier-Veyret, Cordelia Ihl, Marie-Noelle Hilleret, Magalie Baudrant, Xavier Fonrose, Françoise Stanke-Labesque
Unexpected overdose blood concentration of tacrolimus: Keep in mind the role of inflammation. British journal of clinical pharmacology 86 (9) (2020)
Elodie Gautier-Veyret, Anne Thiebaut-Bertrand, Matthieu Roustit, Léa Bolcato, Julie Depeisses, Mathilde Schacherer, Gabriel Schummer, Xavier Fonrose, Françoise Stanke-Labesque
Optimization of voriconazole therapy for treatment of invasive aspergillosis: Pharmacogenomics and inflammatory status need to be evaluated. British journal of clinical pharmacology 87 (6) (2020)
Sébastien Chanoine, Elodie Gautier-Veyret, Hélène Pluchart, Julia Tonini, Xavier Fonrose, Johanna Claustre, Pierrick Bedouch, Françoise Stanke-Labesque
Tablets or oral suspension for posaconazole in lung transplant recipients? Consequences for trough concentrations of tacrolimus and everolimus. British journal of clinical pharmacology 87 (2) (2020)
Benjamin Nemoz, David Ternant, Sébastien Bailly, Elodie Gautier-Veyret, Jean-François Jourdil, Bruno Bonaz, Françoise Stanke-Labesque
New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseases. British journal of clinical pharmacology 85 (4) (2019)